The Wyoming Department of Health has rolled out a new app that seeks to help patients track the health of each member of his or her family. The tool was developed by San Francisco-based Wildflower Health.
An estimated 23,000 deaths can be tied to antibiotic-resistance every year, according to data from the CDC's website.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
This incident doesn't seem to have targeted only patient records. Instead, at least one hack hit food and beverage stations at Banner facilities in four states.
Dan Peterson is an epidemiologist and entrepreneur who started a company last year, Teqqa, to help physicians and healthcare facilities decide which antibiotics they should prescribe for their patients. Its first product — iAntibiogram — is an analytics tool for clinical decision support. It comes on the heels of the Obama administration’s push to improve […]
Missouri is seeing a bigger decline in its Medicaid rolls than nearly any other state, a ranking that the administration of Gov. Jay Nixon attributes to an improving economy and critics blame on application snafus. A new federal report compares Medicaid enrollment in March to the average for the three-month period of July through September 2013. […]
In spite of the Grand Tetons, Wyoming didn’t spring to mind for forging new frontiers in healthcare until I talked to Dr. James Bush, Wyoming Medicaid medical director with the Wyoming Department of Health. With a “maldistribution” of only about 1,000 docs for about 550,000 patients, the state is a perfect candidate for testing out telehealth […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.